KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Short-term Investments (2016 - 2017)

Historic Short-term Investments for Jazz Pharmaceuticals (JAZZ) over the last 4 years, with Q3 2017 value amounting to $200.0 million.

  • Jazz Pharmaceuticals' Short-term Investments rose 23659.83% to $200.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $200.0 million, marking a year-over-year increase of 23659.83%. This contributed to the annual value of $60.0 million for FY2016, which is N/A changed from last year.
  • Jazz Pharmaceuticals' Short-term Investments amounted to $200.0 million in Q3 2017, which was up 23659.83% from $80.0 million recorded in Q2 2017.
  • Over the past 5 years, Jazz Pharmaceuticals' Short-term Investments peaked at $200.0 million during Q3 2017, and registered a low of $764000.0 during Q1 2016.